TRPV1 and migraine disorder: In view of the variable success of migraine treatment with BoNT/A (see Section 1), the ability of this protease to block the CGRP release evoked by activating TRPV1 to different extents with a range of capsaicin concentrations was examined using rat TGNs in culture.